(Q51720712)

10 April 2018

editorial

0 references

title

Advances in structure-based drug design of novel bacterial topoisomerase inhibitors. (English)

1 reference

10 April 2018

author name string

Katherine Widdowson

series ordinal

1

1 reference

10 April 2018

Alan Hennessy

series ordinal

2

1 reference

10 April 2018

publication date

1 November 2010

1 reference

10 April 2018

Future Medicinal Chemistry

published in

1 reference

10 April 2018

volume

2

1 reference

10 April 2018

issue

11

1 reference

10 April 2018

page(s)

1619-1622

1 reference

10 April 2018

Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents

cites work

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.250

DNA gyrase: an enzyme that introduces superhelical turns into DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.250

DNA Gyrase and the Supercoiling of DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.250

A crystal structure of the bifunctional antibiotic simocyclinone D8, bound to DNA gyrase

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.250

Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.250

Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.250

Type IIA topoisomerase inhibition by a new class of antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.250

Mechanism of action of the antibiotic NXL101, a novel nonfluoroquinolone inhibitor of bacterial type II topoisomerases

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.250

21 January 2018

Identifiers

DOI

10.4155/FMC.10.250

1 reference

10 April 2018

1 reference

10 April 2018